Allergen Immunotherapy Extract

DRUG5 trials

Sponsors

Johns Hopkins University, Mansoura University Hospital, Odense University Hospital, Inmunotek S.L.

Conditions

Allergic AsthmaAllergic RhinitisAllergy in ChildrenEfficacy, SelfRhinitisRhinoconjunctivitis

Phase 2

A Novel Biologic Therapy for Perennial Allergic Rhinitis

CompletedNCT03360071

Johns Hopkins UniversityAllergic Rhinitis

Start: 2016-12-19End: 2018-11-01Updated: 2019-09-04

Phase 3

Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df

RecruitingNCT07348302

Inmunotek S.L.Rhinitis, Rhinoconjunctivitis

Start: 2025-04-02End: 2029-07-01Target: 736Updated: 2026-01-16

Unknown Phase

Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma

CompletedNCT05786638

Mansoura University HospitalEfficacy, Self

Start: 2021-10-20End: 2023-03-10Updated: 2023-03-28

Long Term Effect of AIT in Children

RecruitingNCT06421415

Odense University HospitalAllergy in Children

Start: 2024-05-01End: 2037-05-01Target: 100Updated: 2025-07-10

Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy

CompletedNCT07694947

Mansoura University HospitalAllergic Asthma

Start: 2023-01-01End: 2024-01-01Updated: 2026-08-18